Abstract
Introduction

70
Adherence to antiretroviral therapy (ART) is critical in order to achieve viral suppression 71 [1] or the third 90, one of three UNAIDS targets set for achievement before 2020. In 72 order to achieve viral load suppression, patients should take at least 95% of their 73 medications [2] [3] [4] . Although adherence levels in sub Saharan Africa are on average 74 higher than estimates in North America [5] , patients in countries such as Uganda face 75 structural barriers to achieve high level adherence. 76 77 One of the main barriers to adherence is the long distance between one's place of 78 residence and healthcare facilities. [6, 7] Specifically, patients seeking HIV care and 79 treatment travel longer distances compared to their HIV negative counterparts. [8] 80
Several studies have examined geographical factors as barriers and systematic analysis 81 has shown that travel distance is a barrier across the continuum of HIV care from testing 82 to treatment and retention in care [9] . Patients narrate how they struggle to raise the 83 monthly transportation fee to the clinics to collect their medicines [10, 11] . Some patients 84 devised innovative ways such as pooling resources in order to secure their monthly pills, 85 with some patients making two-day arduous journeys to an HIV clinic. Long waiting There is now a need for interventions that not only reduce distance to HIV treatment 100 clinics, but also have potential to decongest them. These may result in better adherence to In the implementation phase, we reviewed the appointment dates for all patients that The typical layout for the clinic at Kitagata Hospital is shown in Figure 1 below.
The circled numbers in Figure 1 represent the positions where the research assistants 224 were positioned to collect the waiting time data.
226
Adherence was measured using self-report. Blood samples were drawn from the patients 227 and sent to a regional testing laboratory in Mbarara for viral load testing. VL were 228 measured using Amplicor system® from Roche. Results were relayed back to the health 229 care providers 4 weeks after sample collection.
231
Sampling, sample size and data analysis 232 We used consecutive sampling to collect baseline data. We aimed to interview 300 study 233 participants at baseline to determine the proportion of participants that were living 234 outside of 5km from the hospital. At the follow up for evaluation, we did not calculate 235 sample size. The number was determined by the resources available to conduct viral load 236 testing, as this was the primary outcome for the evaluation. 237 We summarized the baseline characteristics using 5km as the cut off. This is because the 
Results
257
We conducted baseline assessment interviews among 292 patients at both Kitagata and 258 Itojo Hospital. Almost two thirds were women, with a median age of 37 years. Majority 259 lived more than 5km away from the hospital and the results are shown in Table 1 ------------------Insert Table 1 Table 2 here The mean waiting time at the hospital was 4.48 hours before the intervention and 295 increased to 4.76 hours after the intervention, however this change was not statistically 296 significant (p=0.13) and these results are shown in Table 3 . The proportion of patients 297 who missed an ART dose in the last 30 days dropped from 20% at baseline to 8.5% at 12 298 months after the intervention and this drop was statistically significant (p=0.009).
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Similarly, the proportion of patients with detectable viral load significantly dropped from 300 19.9% to 7.4% after the intervention (p=0.001).
301 302 Table 3 here In this mobile pharmacy intervention for ART in rural western Uganda, there was 314 significant reduction in the proportion of patients who missed an ART dose in the last 30 315 days and a significant decrease in the proportion of patients with detectable viral load.
316
However, the intervention had no impact on the waiting time at the district hospital. 317 318 319
Our intervention targeted participants that lived more than 5km from the hospital and our 320 data indicate this was the right target population. Not only did they take more time to 321 travel to the hospital, they also paid more to reach the facility and reported more 322 difficulty trying to reach it. Yet, these participants who lived further away were more The hospital ART clinics were overcrowded pre-intervention. We hypothesized that 330 MAP would decongest them by taking away a large proportion who needed refills.
331
Despite the intervention, there was no significant decrease in waiting time at the hospital.
332
On closer scrutiny, the lack of decrease in waiting time came as no surprise because the 333 overall ART clinic population for instance at Kitagata grew from 500 patients to almost 334 1000 patients within a year following the implementation of the MAP. 
